Baird analyst Michael Halloran raised the firm’s price target on Xylem (XYL) to $163 from $161 and keeps an Outperform rating on the shares. The firm updated its model following Q1 results as demand remains healthy.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XYL:
- Xylem price target lowered to $168 from $174 at Citi
- Xylem price target lowered to $154 from $156 at Barclays
- Xylem Inc. Balances Margin Gains With China Drag
- Analyst Reiterates Buy on Xylem After Q1 Beat, Raised Revenue Outlook, and Strong Water Metering Momentum
- Xylem reports Q1 adjusted EPS $1.12, consensus $1.08